Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
ARENA PHARMACEUTICALS INC has filed 1,425 SEC EDGAR filings since 28 Apr 2000

SEC filing history

Showing 126-150 of 822 matching filings.

Per page
25
Current page
6
5

FORM 5 SUBMISSION

Filing date
16 Feb 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-59397

ARENA PHARMACEUTICALS, INC.

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-59397

SCHEDULE 13G/A

Filing date
10 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Feb 2021
Reporting date
02 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
04 Feb 2021
Reporting date
04 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-59397

SC 13G/A filing

Filing date
29 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jan 2021
Reporting date
19 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jan 2021
Reporting date
15 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jan 2021
Reporting date
12 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jan 2021
Reporting date
07 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jan 2021
Reporting date
07 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jan 2021
Reporting date
07 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-59397

SEC SCHEDULE 13G

Filing date
11 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

8-K - JPM DECK

Filing date
11 Jan 2021
Reporting date
11 Jan 2021
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Dec 2020
Reporting date
11 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Dec 2020
Reporting date
08 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Dec 2020
Reporting date
08 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Dec 2020
Reporting date
01 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Nov 2020
Reporting date
25 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Nov 2020
Reporting date
25 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Nov 2020
Reporting date
25 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Nov 2020
Reporting date
25 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

8-K - NOVEMBER 2020 CORPORATE PRESENTATION

Filing date
18 Nov 2020
Reporting date
18 Nov 2020
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .